0001171843-17-005068.txt : 20170814
0001171843-17-005068.hdr.sgml : 20170814
20170814180616
ACCESSION NUMBER: 0001171843-17-005068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170814
FILED AS OF DATE: 20170814
DATE AS OF CHANGE: 20170814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayden Michael R
CENTRAL INDEX KEY: 0001352908
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 171031944
MAIL ADDRESS:
STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION
STREET 2: 1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: V8Z 7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
4
1
formfour.xml
OWNERSHIP DOCUMENT
X0306
4
2017-08-14
0
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001352908
Hayden Michael R
C/O XENON PHARMACEUTICALS INC
200 - 3650 GILMORE WAY
BURNABY
A1
V5G 4W8
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Shares
2017-08-14
4
P
0
15000
2.7498
A
161187
D
Common Shares
75886
I
By Wife
Common Shares
30348
I
By Genworks Inc.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $2.745 to $2.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Michael Hayden is the president and principal beneficial shareholder of Genworks Inc.
/s/ Joanne Smartt, Attorney-in-fact
2017-08-14